Evidence map›Paper›PMID 24879558›Full record

ArticleGenome research2014

Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotency.

Marc Friedli, Priscilla Turelli, Adamandia Kapopoulou, Benjamin Rauwel, Nathaly Castro-Díaz, Helen M Rowe, Gabriela Ecco, Carmen Unzu, Evarist Planet, Angelo Lombardo and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Repetitive Sequence Stability in Embryonic Stem Cells.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Human Endogenous Retroviruses in Diseases.Sub-cellular biochemistry · 2023
    Article
  7. Article
  8. Transposon control as a checkpoint for tissue regeneration.Development (Cambridge, England) · 2022
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Marc FriedliSchool of Life Sciences and "Frontiers in Genetics" National Program, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland;
Priscilla TurelliSchool of Life Sciences and "Frontiers in Genetics" National Program, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland;
Adamandia KapopoulouSchool of Life Sciences and "Frontiers in Genetics" National Program, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland;
Benjamin RauwelSchool of Life Sciences and "Frontiers in Genetics" National Program, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland;
Nathaly Castro-DíazSchool of Life Sciences and "Frontiers in Genetics" National Program, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland;
Helen M RoweSchool of Life Sciences and "Frontiers in Genetics" National Program, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland;
Gabriela EccoSchool of Life Sciences and "Frontiers in Genetics" National Program, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland;
Carmen UnzuPediatric Surgery Laboratory, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland;
Evarist PlanetSchool of Life Sciences and "Frontiers in Genetics" National Program, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland;
Angelo LombardoSan Raffaele Telethon Institute for Gene Therapy and Vita Salute San Raffaele University, 20132 Milan, Italy;
Bastien MangeatDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
Barbara E WildhaberPediatric Surgery Laboratory, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland;
Luigi NaldiniSan Raffaele Telethon Institute for Gene Therapy and Vita Salute San Raffaele University, 20132 Milan, Italy;
Didier TronoSchool of Life Sciences and "Frontiers in Genetics" National Program, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland; didier.trono@epfl.ch.
École Polytechnique Fédérale de Lausanne · CHUniversity of Geneva · CHVita-Salute San Raffaele University · IT

Funding

European Research Council 249845European Research Council 268721Telethon TGT11D02Wellcome Trust 101200
6 · The paper itself

Abstract

Endogenous retroelements (EREs) account for about half of the mouse or human genome, and their potential as insertional mutagens and transcriptional perturbators is suppressed by early embryonic epigenetic silencing. Here, we asked how ERE control is maintained during the generation of induced pluripotent stem cells (iPSCs), as this procedure involves profound epigenetic remodeling. We found that all EREs tested were markedly up-regulated during the reprogramming of either mouse embryonic fibroblasts, human CD34(+) cells, or human primary hepatocytes. At the iPSC stage, EREs of some classes were repressed, whereas others remained highly expressed, yielding a pattern somewhat reminiscent of that recorded in embryonic stem cells. However, variability persisted between individual iPSC clones in the control of specific ERE integrants. Both during reprogramming and in iPS cells, the up-regulation of specific EREs significantly impacted on the transcription of nearby cellular genes. While transcription triggered by specific ERE integrants at highly precise developmental stages may be an essential step toward obtaining pluripotent cells, the broad and unspecific unleashing of the repetitive genome observed here may contribute to the inefficiency of the reprogramming process and to the phenotypic heterogeneity of iPSCs.

Indexed as

TranscriptomeAnimalsCells, CulturedCellular ReprogrammingEndogenous RetrovirusesGene SilencingHumansInduced Pluripotent Stem CellsMiceUp-Regulation

Identifiers

PMID24879558
PMCPMC4120079
OpenAlexW2162919974

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.